Home › Companies › UTAH MEDICAL PRODUCTS INC. › 2023-2024
Compiled from SEC Form N-PX filings and UTAH MEDICAL PRODUCTS INC.’s Form 8-K, filed May 6, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of May 3, 2024: 3 items on UTAH MEDICAL PRODUCTS INC.’s Form 8-K, filed May 6, 2024: 3 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore UTAH MEDICAL PRODUCTS INC. in the interactive database Compare manager voting policies
These tallies are UTAH MEDICAL PRODUCTS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 6, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elected Paul O. Richins as a director of the Company: | 907,483 | -- | -- | 1,833,586 | 324,644 | 33% | Not verified | — |
| Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2024: | 3,012,801 | 49,443 | 3,469 | -- | -- | 98% | Not verified | — |
| Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: | 2,662,106 | 72,899 | 6,064 | -- | 324,644 | 97% | Not verified | — |
Source: UTAH MEDICAL PRODUCTS INC., Form 8-K, filed with the SEC on May 6, 2024 — read the filing on EDGAR.
Each item below shows how the 153 asset managers that disclosed a UTAH MEDICAL PRODUCTS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of UTAH MEDICAL PRODUCTS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
46.7% of fund votes cast · no official result
Description as filed by funds: To elect two directors of the Company to serve a three year term and until their successor is elected and qualified: Kevin L. Cornwell
The 58 asset managers below reported 606,740 for, 2,080 against, 691,800 withheld, 60 unknown. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 69,332 | 0 | 0 | 319,145 | Mixed |
| Vanguard | 165,572 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 144,497 | Withhold |
| JPMorgan | 111,018 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 110,632 | Withhold |
| BlackRock | 105,217 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 0 | 0 | 0 | 41,696 | Withhold |
| Russell Investments | 26,730 | 0 | 0 | 0 | For |
| WisdomTree | 0 | 0 | 0 | 21,769 | Withhold |
| Royce | 15,114 | 0 | 0 | 0 | For |
| Charles Schwab | 14,172 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 12,056 | 0 | 0 | 0 | For |
| TIAA | 11,179 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 10,948 | Withhold |
| Equitable | 6,018 | 0 | 0 | 4,800 | Mixed |
| SEI | 9,952 | 0 | 0 | 0 | For |
| HOTCHKIS & WILEY FUNDS /DE/ | 0 | 0 | 0 | 9,900 | Withhold |
| Goldman Sachs | 9,271 | 0 | 0 | 0 | For |
| BRANDES INVESTMENT TRUST | 8,425 | 0 | 0 | 0 | For |
| Principal | 0 | 0 | 0 | 7,988 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 5,891 | 0 | 0 | 0 | For |
| Lincoln Financial | 2,915 | 0 | 0 | 2,100 | Mixed |
| Nationwide | 3,854 | 0 | 0 | 936 | Mixed |
| American Century | 0 | 0 | 0 | 4,726 | Withhold |
| Columbia Threadneedle | 4,600 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 3 wordings of this item as funds reported it.
30% of fund votes cast · no official result
Description as filed by funds: To elect two directors of the Company to serve a three year term and until their successor is elected and qualified: Paul O. Richins
The 58 asset managers below reported 392,876 for, 2,080 against, 905,664 withheld, 60 unknown. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 69,332 | 0 | 0 | 319,145 | Mixed |
| Vanguard | 165,572 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 144,497 | Withhold |
| JPMorgan | 111,018 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 110,632 | Withhold |
| BlackRock | 0 | 0 | 0 | 105,217 | Withhold |
| FRANKLIN VALUE INVESTORS TRUST | 0 | 0 | 0 | 41,696 | Withhold |
| Russell Investments | 26,730 | 0 | 0 | 0 | For |
| WisdomTree | 0 | 0 | 0 | 21,769 | Withhold |
| Royce | 15,114 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 14,172 | Withhold |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 12,056 | Withhold |
| TIAA | 0 | 0 | 0 | 11,179 | Withhold |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 10,948 | Withhold |
| Equitable | 0 | 0 | 0 | 10,818 | Withhold |
| SEI | 0 | 0 | 0 | 9,952 | Withhold |
| HOTCHKIS & WILEY FUNDS /DE/ | 0 | 0 | 0 | 9,900 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 9,271 | Withhold |
| BRANDES INVESTMENT TRUST | 0 | 0 | 0 | 8,425 | Withhold |
| Principal | 0 | 0 | 0 | 7,988 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 5,891 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 5,015 | Withhold |
| Nationwide | 0 | 0 | 0 | 4,790 | Withhold |
| American Century | 0 | 0 | 0 | 4,726 | Withhold |
| Columbia Threadneedle | 0 | 0 | 0 | 4,600 | Withhold |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 8 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To approve, by advisory vote, the Company's executive compensation program;
UTAH MEDICAL PRODUCTS INC.’s own tally for this item (“Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:”): 2,662,106 for, 72,899 against, per its Form 8-K filed May 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 388,477 | 0 | 0 | 0 | For |
| Vanguard | 165,572 | 0 | 0 | 0 | For |
| Dimensional | 144,497 | 0 | 0 | 0 | For |
| JPMorgan | 111,018 | 0 | 0 | 0 | For |
| T. Rowe Price | 110,632 | 0 | 0 | 0 | For |
| BlackRock | 105,217 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 41,696 | 0 | 0 | 0 | For |
| WisdomTree | 21,769 | 0 | 0 | 0 | For |
| Royce | 15,114 | 0 | 0 | 0 | For |
| TIAA | 11,179 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 10,948 | 0 | 0 | 0 | For |
| Equitable | 10,818 | 0 | 0 | 0 | For |
| HOTCHKIS & WILEY FUNDS /DE/ | 9,900 | 0 | 0 | 0 | For |
| Goldman Sachs | 9,271 | 0 | 0 | 0 | For |
| Principal | 7,988 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 5,891 | 0 | 0 | 0 | For |
| Lincoln Financial | 5,015 | 0 | 0 | 0 | For |
| American Century | 0 | 4,726 | 0 | 0 | Against |
| Nationwide | 4,685 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 4,600 | 0 | 0 | 0 | For |
| Northern Trust | 4,483 | 0 | 0 | 0 | For |
| Invesco | 4,224 | 0 | 0 | 0 | For |
| Voya | 3,035 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,600 | 0 | 0 | 0 | For |
| RANGER FUNDS INVESTMENT TRUST | 2,080 | 0 | 0 | 0 | For |
Fund voting reports, all 48 managers: 1,216,169 for, 4,726 against, 60 unknown. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 383,435 | 0 | 0 | 0 | For |
| T. Rowe Price | 190,600 | 0 | 0 | 0 | For |
| Renaissance | 188,653 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 73,254 | 0 | 0 | 0 | For |
| State Street | 68,424 | 0 | 0 | 0 | For |
| BlackRock | 61,880 | 0 | 0 | 0 | For |
| Ranger Investment Management, L.P. | 51,017 | 0 | 0 | 0 | For |
| FRANKLIN MUTUAL ADVISERS LLC | 41,696 | 0 | 0 | 0 | For |
| Clean Yield Group | 31,194 | 0 | 0 | 0 | For |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 31,020 | 0 | 0 | 0 | For |
| Citadel | 26,923 | 0 | 0 | 0 | For |
| Two Sigma | 21,113 | 0 | 0 | 0 | For |
| ISTHMUS PARTNERS, LLC | 20,389 | 0 | 0 | 0 | For |
| Dimensional | 15,130 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 13,421 | 0 | 0 | 0 | For |
| Natixis | 11,704 | 0 | 0 | 0 | For |
| Nuveen | 11,229 | 0 | 0 | 0 | For |
| Penn Mutual Asset Management | 10,948 | 0 | 0 | 0 | For |
| DE Shaw | 10,114 | 0 | 0 | 0 | For |
| American Century | 0 | 9,398 | 0 | 0 | Against |
| Goldman Sachs | 7,753 | 0 | 0 | 0 | For |
| Northern Trust | 7,638 | 0 | 0 | 0 | For |
| Vanguard | 6,454 | 0 | 0 | 0 | For |
| GLOBEFLEX CAPITAL L P | 6,336 | 0 | 0 | 0 | For |
| STRS OHIO | 5,500 | 0 | 0 | 0 | For |
Institutional-manager reports, all 92 managers: 1,343,057 for, 10,036 against. Showing the 25 largest; see all in the interactive database.
97% Majority: yes · of votes cast
Description as filed by funds: To hold an advisory vote on the Company s executive compensation program.
UTAH MEDICAL PRODUCTS INC.’s own tally for this item (“Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:”): 2,662,106 for, 72,899 against, per its Form 8-K filed May 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Russell Investments | 26,730 | 0 | 0 | 0 | For |
| Charles Schwab | 14,172 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 12,056 | 0 | 0 | 0 | For |
| SEI | 9,952 | 0 | 0 | 0 | For |
| BRANDES INVESTMENT TRUST | 8,425 | 0 | 0 | 0 | For |
| ADVISORS' INNER CIRCLE FUND | 2,729 | 0 | 0 | 0 | For |
| Global X | 1,629 | 0 | 0 | 0 | For |
| NEW COVENANT FUNDS | 515 | 0 | 0 | 0 | For |
| Nationwide | 105 | 0 | 0 | 0 | For |
Fund voting reports, all 9 managers: 76,313 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RICE HALL JAMES & ASSOCIATES, LLC | 61,611 | 0 | 0 | 0 | For |
| BRANDES INVESTMENT PARTNERS, LP | 54,597 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0 | 24,186 | 0 | 0 | Against |
| Charles Schwab | 14,172 | 0 | 0 | 0 | For |
| SEI | 9,952 | 0 | 0 | 0 | For |
| LSV ASSET MANAGEMENT | 7,647 | 915 | 0 | 0 | Mixed |
| Russell Investments | 8,170 | 0 | 0 | 0 | For |
| Riverwater Partners LLC | 2,330 | 0 | 0 | 0 | For |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 2,311 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 1,429 | 0 | 0 | 0 | For |
| Man Group plc | 950 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 751 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 548 | 0 | 0 | 0 | For |
| Prudential/PGIM | 354 | 0 | 0 | 0 | For |
| OREGON PUBLIC EMPLOYEES RETIREMENT FUND | 306 | 0 | 0 | 0 | For |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 293 | 0 | 0 | 0 | For |
| MACKENZIE FINANCIAL CORP | 237 | 0 | 0 | 0 | For |
| Neuberger Berman | 192 | 0 | 0 | 0 | For |
| YOUSIF CAPITAL MANAGEMENT, LLC | 30 | 0 | 0 | 0 | For |
Institutional-manager reports, all 19 managers: 165,880 for, 25,101 against, 454 not voted.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Advisory Vote to Ratify Named Executive Officers' Compensation
UTAH MEDICAL PRODUCTS INC.’s own tally for this item (“Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:”): 2,662,106 for, 72,899 against, per its Form 8-K filed May 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 4 asset managers below reported 65,777 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 61,397 | 0 | 0 | 0 | For |
| Penobscot Investment Management Company, Inc. | 4,000 | 0 | 0 | 0 | For |
| ALGERT GLOBAL LLC | 260 | 0 | 0 | 0 | For |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma | 120 | 0 | 0 | 0 | For |
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To ratify the selection of Haynie & Company as the Company's independent public accounting firm for the year ending December 31, 2024;
UTAH MEDICAL PRODUCTS INC.’s own tally for this item (“Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2024:”): 3,012,801 for, 49,443 against, per its Form 8-K filed May 6, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 1,393,635 for, 60 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 388,477 | 0 | 0 | 0 | For |
| Vanguard | 165,572 | 0 | 0 | 0 | For |
| Dimensional | 144,497 | 0 | 0 | 0 | For |
| JPMorgan | 111,018 | 0 | 0 | 0 | For |
| T. Rowe Price | 110,632 | 0 | 0 | 0 | For |
| BlackRock | 105,217 | 0 | 0 | 0 | For |
| FORUM FUNDS II | 96,427 | 0 | 0 | 0 | For |
| FRANKLIN VALUE INVESTORS TRUST | 41,696 | 0 | 0 | 0 | For |
| Russell Investments | 26,730 | 0 | 0 | 0 | For |
| WisdomTree | 21,769 | 0 | 0 | 0 | For |
| Royce | 15,114 | 0 | 0 | 0 | For |
| Charles Schwab | 14,172 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 12,056 | 0 | 0 | 0 | For |
| TIAA | 11,179 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 10,948 | 0 | 0 | 0 | For |
| Equitable | 10,818 | 0 | 0 | 0 | For |
| SEI | 9,952 | 0 | 0 | 0 | For |
| HOTCHKIS & WILEY FUNDS /DE/ | 9,900 | 0 | 0 | 0 | For |
| Goldman Sachs | 9,271 | 0 | 0 | 0 | For |
| BRANDES INVESTMENT TRUST | 8,425 | 0 | 0 | 0 | For |
| Principal | 7,988 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 5,891 | 0 | 0 | 0 | For |
| Lincoln Financial | 5,015 | 0 | 0 | 0 | For |
| Nationwide | 4,790 | 0 | 0 | 0 | For |
| American Century | 4,726 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 3,589,014 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 10.82% |
| 2 | Vanguard | 4.61% |
| 3 | Dimensional | 4.03% |
| 4 | JPMorgan | 3.09% |
| 5 | T. Rowe Price | 3.08% |
| 6 | BlackRock | 2.93% |
| 7 | FRANKLIN VALUE INVESTORS TRUST | 1.16% |
| 8 | Russell Investments | 0.74% |
| 9 | WisdomTree | 0.61% |
| 10 | Royce | 0.42% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 10.68% |
| 2 | T. Rowe Price | 5.31% |
| 3 | Renaissance | 5.26% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 2.04% |
| 5 | State Street | 1.91% |
| 6 | BlackRock | 1.72% |
| 7 | Ranger Investment Management, L.P. | 1.42% |
| 8 | FRANKLIN MUTUAL ADVISERS LLC | 1.16% |
| 9 | Clean Yield Group | 0.87% |
| 10 | HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 0.86% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Renaissance Technologies | 6.48% | 13F |
| BlackRock | 5.01% | 13F |
| Vanguard Group | 4.89% | 13F |
| Dimensional Fund Advisors | 4.50% | 13F |
| State Street | 2.25% | 13F |
| Geode Capital | 2.05% | 13F |
| Morgan Stanley | 1.60% | 13F |
| Millennium Management | 1.41% | 13F |
| BNY Mellon | 1.34% | 13F |
| Franklin Templeton | 1.17% | 13F |
Percentages above are of 3,589,014 shares outstanding, as reported by UTAH MEDICAL PRODUCTS INC. on its Form 10-K dated March 25, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from UTAH MEDICAL PRODUCTS INC.’s 10-K dated March 25, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At UTAH MEDICAL PRODUCTS INC.'s shareholder meeting held May 3, 2024, in the 2023-2024 proxy season, 153 asset managers reported how they voted in their SEC Form N-PX filings, covering 805 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, by advisory vote, the Company's executive compensation program; — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: UTAH MEDICAL PRODUCTS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 6, 2024.
UTAH MEDICAL PRODUCTS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.